期刊文献+

精神分裂症和抑郁症患者体感诱发电位的初步研究 被引量:4

Somatosensoryevokedpotentialinschizophreniaaneedpression:apreliminaryinvestigation
原文传递
导出
摘要 为观察精神分裂症和抑郁症患者体感诱发电位(SEP)的变化,使用CA-1000诱发电位叠加仪对41例精神分裂症患者及29例抑郁症患者SEP进行观察,并与25名正常人比较。结果显示,精神分裂症患者SEP波型变异大,P2,N2及P3波潜伏期明显缩短,主波P2平均波幅较抑郁症和正常人组分别降低40%及63%,N1-P1,P2-N2及P3波波幅亦显著降低,与抑郁症和正常人组间均有显著或非常显著性差异。抑郁症患者P2波平均波幅比正常人组降低30%,与正常人组有非常显著性差异。提示对SEP作为精神科临床诊断和家系研究中易感素质筛选方面的生物学标记。 Theaimofthisstudywastoobservethevariationsofsomatosensoryevokedpotentials(SEP)inschizophreniaanddepression.In41schizophrenicand29depressivepatientsaccordingtothecriteriaofChineseCategoriesofMentalDisorders,2nded,theSEPhavebeenexaminedwithCA-1000summatorandcomparedwith25normaladults.Theresultsshowedthatthewaveformsintheschizophrenicsweremorevari-ablethanthoseofthenormalsubjects.TheSEPlatencyP2,N2andP3inschizophrenicsweresignificantlyshorterthanthoseofthedepressivepatientsandnormaladults(P<0.01).ItwasshowedthattheSEPaverageamplitudeP2inschizophrenicsreduced40%and63%re-spectivelyincomparisonwiththedepres-sivepatientsandnormaladults.TheSEPamplitudesN1-P1,P2-N2andP3inschizophrenicsweresignificantlylowerthanthoseofthedepressivepatientsandnormaladults(P<0.01),whiletheSEPaverageamplitudeP2inthedepressivepatientsreduced30%incom-parisonwithnormaladults(P<0.01).ThefurtherinvestigationshouldbeconductedinordertoproveSEPcouldserveasabiologicalmarkerindiagnosingthepsychoticdisordersandscreeningforthevulner-abilitiesamongtherelevantfamilymembers.
出处 《中华精神科杂志》 CAS CSCD 1996年第3期16-19,共4页 Chinese Journal of Psychiatry
关键词 精神分裂症 抑郁症 诱发电位 躯体感觉 chizophreniaDepressionEvokedpotentials,somatosensory
  • 相关文献

参考文献1

二级参考文献1

  • 1战胜才,康维礼.正常人体感诱发电位的研究[J]神经精神疾病杂志,1982(01).

共引文献1

同被引文献41

  • 1王宗叶,张丽.哈伯因对精神分裂症记忆障碍的疗效[J].临床精神医学杂志,2004,14(5):280-281. 被引量:6
  • 2向云.精神分裂症与认知功能障碍[J].中国行为医学科学,2005,14(7):620-622. 被引量:65
  • 3胡峻梅 秦小荣 等.慢性精神分裂症阴阳性症状量表的应用研究[J].四川精神医学,1993,6(3).
  • 4Elliott R. Executive functions and their disorders.Imaging neuroscience: Clinical frontiers for diagnosis and management.Br Med Bull,2003,65:49-59.
  • 5Carlsson A, Hansson LO. A glutaergic deficiency model of schizophrenia. Br J Psychiatry, 1999,174(Suppl 37):2.
  • 6Wassef A,Baker J, Kochan LD. GABA and Schizophrenia: A review of basic science and clinical studies. J Clin Psychopharmacology, 2003,23(6):601-640.
  • 7Stip E,Remington GJ, Dursun S, et al. A Canadian Multicenter Trial Assessing Memory and Executive Functions in Patients With Schizophrenia Spectrum Disorders Treated With Olanzapine.J Clin Psychopharmacology, 2003,23(4):400-404.
  • 8Goldberg TE, Torrey EF, Davidso R, et al. Risk of neuropsychological impairment in monozygotic twins discordant and concordant for schizophrenia. Schizophr Res,1995,17:77-84.
  • 9Medalia A, Lim R. Treatment of Cognitive Dysfunction in Psychiatric Disorders. Journal of Psychiatric Practice,2004,10(1):17-25.
  • 10Hoff AL,Kremen WS. Is there a cognitive phenotype for schizophrenia: the nature and course of the disturbance in cognition? Current Opinion in Psychiatry, 2002,15(1):43-48.

引证文献4

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部